On Friday, Alibaba Group Holding Ltd (NYSE:BABA)’s shares declined -1.81% to $84.58, as Costco Wholesale Corporation and Alibaba Group’s Tmall Global platform issued the following joint statement regarding false claims of distribution channels of Costco products sold in China:
Costco’s Tmall Global store is the only online Costco flagship store in China. Customers are welcome to shop for authentic Costco products through Tmall Global. Costco reserves the right to take legal action against any unauthorized sites on other platforms.
Alibaba Group Holding Limited, through its auxiliaries, works as an online and mobile commerce corporation in the People’s Republic of China and internationally. It operates Taobao Marketplace, an online shopping destination; Tmall, a third-party platform for brands and retailers; Juhuasuan, a group buying marketplace; Alibaba.com, an online business-to-business marketplace that focuses on global trade among businesses; 1688.com, an online wholesale marketplace; and AliExpress, a consumer marketplace.
Inovio Pharmaceuticals Inc (NASDAQ:INO)’s shares dropped -1.81% to $9.78, during the last trading session on Friday, as Inovio Pharmaceuticals, declared that it was recognized with a prestigious industry award at the World Vaccine Congress being held this week in Washington, D.C. The Vaccine Industry Excellence (ViE) Awards honor outstanding vaccine advancements and achievements of therapeutic and preventive vaccine developers across the worldwide industry as judged by a panel of global biotech industry stakeholders.
These positive results represent the first study and first report of T cell immune responses generated in cancer patients after treatment with an Inovio DNA immunotherapy. The magnitude and characteristics of these interim immune response data mirror immune responses formerly observed in human studies of VGX-3100 for HPV-associated cervical dysplasia; in a placebo-controlled phase II study, strong T cell immune responses were positively correlated with achievement of primary and secondary efficacy endpoints.
Inovio Pharmaceuticals, Inc., a clinical stage biopharmaceutical corporation, develops active DNA immunotherapies and vaccines in combination with proprietary electro oration delivery devices to prevent and treat cancers and infectious diseases.
At the end of Friday’s trade, Synergy Resources Corp (NYSEMKT:SYRG)‘s shares dipped -1.73% to $11.92, as Synergy Resources Corporation, stated its fiscal second quarter results for the period ended February 28, 2015.
Second Quarter 2015 Financial Results
- Proceeds raised 3% to $23.7 million up from $23.0 million in the same quarter a year ago. The year-over-year improvement was attributed to a 98% raise in production, primarily from the new horizontal wells brought on line and production from the Bayswater attainment that closed in December 2014. Proceed growth was offset by a 48% decrease in the realized average selling price per BOE. During fiscal Q2 2015, average selling prices were $43.51 per barrel of oil and $3.38 per mcf of gas, as contrast to $86.82 and $5.93, respectively, a year ago.
- Net revenue was $4.7 million or $0.05 per basic and diluted share, down from $5.2 million or $0.07 per basic and diluted share in the same year-ago period.
Synergy Resources Corporation engages in the attainment, development, exploitation, exploration, and production of oil and natural gas properties primarily located in the Denver-Julesburg Basin in northeast Colorado.
Baidu Inc (ADR) (NASDAQ:BIDU), ended its Friday’s trading session with -1.69% loss, and closed at $214.79, as the leading Chinese language Internet search provider, declared that it will report its financial results for the first quarter ended March 31, 2015, after the U.S. market closes on April 29, 2015. Baidu’s administration will hold an earnings conference call at 8:00 PM on April 29, 2015, U.S. Eastern Time.
Baidu, Inc. provides Internet search services in China and internationally. It offers Chinese language search platform on its Baidu.com Website that enables users to find relevant information online, counting Web pages, news, images, documents, and multimedia files through links offered on its Website; and international products and services to users in other countries.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
